Fairchem Organics Toekomstige groei
Future criteriumcontroles 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Fairchem Organics.
Belangrijke informatie
n/a
Groei van de winst
n/a
Groei van de winst per aandeel
| Chemicals winstgroei | 21.0% |
| Inkomstengroei | n/a |
| Toekomstig rendement op eigen vermogen | n/a |
| Dekking van analisten | None |
| Laatst bijgewerkt | n/a |
Recente toekomstige groei-updates
Geen updates
Recent updates
Capital Investments At Fairchem Organics (NSE:FAIRCHEMOR) Point To A Promising Future
Oct 09
We Discuss Why Fairchem Organics Limited's (NSE:FAIRCHEMOR) CEO Compensation May Be Closely Reviewed
Jul 30Fairchem Organics (NSE:FAIRCHEMOR) Has Announced A Dividend Of ₹7.50
Jul 26Fairchem Organics' (NSE:FAIRCHEMOR) Dividend Will Be ₹7.50
Jul 12Fairchem Organics (NSE:FAIRCHEMOR) Has Affirmed Its Dividend Of ₹7.50
Jun 19Fairchem Organics (NSE:FAIRCHEMOR) Has Announced A Dividend Of ₹7.50
May 30Fairchem Organics (NSE:FAIRCHEMOR) Has A Pretty Healthy Balance Sheet
Mar 13Fairchem Organics' (NSE:FAIRCHEMOR) Shareholders Will Receive A Smaller Dividend Than Last Year
Jul 29Fairchem Organics (NSE:FAIRCHEMOR) Is Paying Out Less In Dividends Than Last Year
Jul 15Fairchem Organics' (NSE:FAIRCHEMOR) Dividend Will Be Reduced To ₹7.50
Jun 02Under The Bonnet, Fairchem Organics' (NSE:FAIRCHEMOR) Returns Look Impressive
Apr 26Fairchem Organics Limited's (NSE:FAIRCHEMOR) Popularity With Investors Is Under Threat From Overpricing
Feb 08Fairchem Organics (NSE:FAIRCHEMOR) Is Very Good At Capital Allocation
Nov 01We Think You Should Be Aware Of Some Concerning Factors In Fairchem Organics' (NSE:FAIRCHEMOR) Earnings
May 25Investors Shouldn't Overlook Fairchem Organics' (NSE:FAIRCHEMOR) Impressive Returns On Capital
Jan 10In dit gedeelte presenteren we gewoonlijk prognoses voor de omzet- en winstgroei op basis van de consensusramingen van professionele analisten om beleggers te helpen begrijpen in hoeverre het bedrijf in staat is winst te genereren. Maar omdat Fairchem Organics onvoldoende gegevens uit het verleden heeft verstrekt en geen analistenprognose heeft, kan de toekomstige winst niet betrouwbaar worden berekend door gegevens uit het verleden te extrapoleren of analistenprognoses te gebruiken.
Dit is een vrij zeldzame situatie, aangezien 97% van de bedrijven die worden gedekt door SimplyWall St wel financiële gegevens uit het verleden hebben.
Winst- en omzetgroeiprognoses
| Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
|---|---|---|---|---|---|
| 6/30/2024 | 6,258 | 482 | N/A | N/A | N/A |
| 3/31/2024 | 6,215 | 405 | 564 | 745 | N/A |
| 12/31/2023 | 6,128 | 406 | N/A | N/A | N/A |
| 9/30/2023 | 5,672 | 289 | 2 | 178 | N/A |
| 6/30/2023 | 5,835 | 226 | N/A | N/A | N/A |
| 3/31/2023 | 6,480 | 435 | 349 | 496 | N/A |
| 12/31/2022 | 6,738 | 428 | N/A | N/A | N/A |
| 9/30/2022 | 7,297 | 557 | 286 | 513 | N/A |
| 6/30/2022 | 7,292 | 726 | N/A | N/A | N/A |
| 3/31/2022 | 6,432 | 679 | 59 | 405 | N/A |
| 12/31/2021 | 6,249 | 755 | N/A | N/A | N/A |
| 9/30/2021 | 5,736 | 754 | 521 | 902 | N/A |
| 6/30/2021 | 5,006 | 636 | N/A | N/A | N/A |
| 3/31/2021 | 3,966 | 425 | 165 | 396 | N/A |
| 12/31/2020 | 201 | 2 | N/A | N/A | N/A |
| 3/31/2020 | 3,065 | 347 | 8 | 312 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: Insufficient data to determine if FAIRCHEMOR's forecast earnings growth is above the savings rate (6.7%).
Winst versus markt: Insufficient data to determine if FAIRCHEMOR's earnings are forecast to grow faster than the Indian market
Hoge groeiwinsten: Insufficient data to determine if FAIRCHEMOR's earnings are expected to grow significantly over the next 3 years.
Omzet versus markt: Insufficient data to determine if FAIRCHEMOR's revenue is forecast to grow faster than the Indian market.
Hoge groei-inkomsten: Insufficient data to determine if FAIRCHEMOR's revenue is forecast to grow faster than 20% per year.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Insufficient data to determine if FAIRCHEMOR's Return on Equity is forecast to be high in 3 years time